Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (SHA:600436)
China flag China · Delayed Price · Currency is CNY
129.56
-1.32 (-1.01%)
Nov 18, 2026, 3:00 PM CST

SHA:600436 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
7,8768,96910,75610,0368,6748,004
Other Revenue
32.2732.2731.8722.3119.5217.29
7,9099,00110,78810,0588,6948,022
Revenue Growth
-19.13%-16.56%7.25%15.70%8.38%23.20%
Cost of Revenue
5,1295,7326,1895,3634,7353,968
Gross Profit
2,7803,2704,5994,6953,9594,054
Selling, General & Admin
918.99760.19858.091,150814.411,027
Research & Development
266.52252.23269.59232.35230.03199.51
Other Operating Expenses
59.730.4447.8170.7771.9672.05
Operating Expenses
1,2981,0721,1781,4651,1101,306
Operating Income
1,4812,1983,4203,2302,8492,748
Interest Expense
-29.36-31.75-37.62-37.31-38.01-32.9
Interest & Investment Income
55.1367.91182.59170.81171.62144.48
Currency Exchange Gain (Loss)
-0.88-0.887.573.097.18-3.28
Other Non Operating Income (Expenses)
7.15.12-3.036.02-36.47-21.62
EBT Excluding Unusual Items
1,5132,5383,5703,3732,9542,834
Gain (Loss) on Sale of Investments
-7.18-9.76-8.958.32-0.024.54
Gain (Loss) on Sale of Assets
23.83.870.9611.1427.59
Asset Writedown
-4.2----0.33-1.02
Other Unusual Items
2.225.61-25.92-13.0613.183.55
Pretax Income
1,5062,5383,5393,3692,9782,869
Income Tax Expense
244.39394.55543.21517.77454.76404.23
Earnings From Continuing Operations
1,2622,1432,9962,8512,5232,465
Minority Interest in Earnings
55.0915.35-18.52-53.79-50.63-32.9
Net Income
1,3172,1592,9772,7972,4722,432
Net Income to Common
1,3172,1592,9772,7972,4722,432
Net Income Growth
-45.57%-27.49%6.42%13.15%1.66%45.49%
Shares Outstanding (Basic)
604603604603603603
Shares Outstanding (Diluted)
604603604603603603
Shares Change
0.08%-0.15%0.16%-0.02%-0.07%0.00%
EPS (Basic)
2.183.584.934.644.104.03
EPS (Diluted)
2.183.584.934.644.104.03
EPS Growth
-45.62%-27.38%6.25%13.17%1.74%45.49%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,321-262.77245.412,0656,698370.11
Free Cash Flow Per Share
2.19-0.440.413.4211.110.61
Dividend Per Share
4.0402.9702.9702.3201.2501.210
Dividend Growth
121.98%0%28.02%85.60%3.31%34.44%
Gross Margin
35.15%36.32%42.63%46.68%45.54%50.53%
Operating Margin
18.73%24.42%31.70%32.11%32.77%34.25%
Profit Margin
16.65%23.98%27.60%27.81%28.44%30.32%
Free Cash Flow Margin
16.70%-2.92%2.27%20.53%77.04%4.61%
EBITDA
1,5802,2783,4753,2982,8972,854
EBITDA Margin
19.98%25.30%32.21%32.79%33.32%35.58%
D&A For EBITDA
98.7179.985567.8247.36106.25
EBIT
1,4812,1983,4203,2302,8492,748
EBIT Margin
18.73%24.42%31.70%32.11%32.77%34.25%
Effective Tax Rate
16.23%15.55%15.35%15.37%15.27%14.09%
Revenue as Reported
7,9099,00110,78810,0588,6948,022
Advertising Expenses
-127.7258.62531.48255.04445